In fact, inhibiting mTOR via drugs, such as everolimus and rapamycin, has slowed down granuloma formation in preclinical animal studies.27 To our knowledge, no papers have specifically referenced a relationship between everolimus to sarcoidosis; nonetheless, our method was able to generate a treatment hypothesis based on previous treatment mechanism (mTOR inhibition) and the pathogenesis of the disease (granuloma formation). The gene discussed is MTOR; the disease is sarcoidosis.